Annalyn Gilchrist

Annalyn Gilchrist has extensive experience in the biotechnology industry, with a focus on marketing, product planning, and market research. Their most recent role was as the Director of New Product Planning at Dyne Therapeutics since 2021. Prior to that, they worked at bluebird bio as the Associate Director of cALD Global/US Marketing from 2020 to 2021. Annalyn also has a long history with Sanofi Genzyme, where they held various positions including Associate Director of Acid Sphinogomyelinase Deficiency Global Marketing from 2017 to 2020, Associate Director of New Product Planning for the Rare Disease Franchise from 2016 to 2017, and Senior Manager of Global Market Research from 2014 to 2016. Before joining Sanofi Genzyme, they worked at Genzyme as the Principal Analyst of Competitive and Technical Intelligence from 2009 to 2011. Annalyn's career began at Genstruct in 2007, where they served as a Scientist I.

Annalyn Gilchrist holds a PhD in Cell Biology with a specialization in Proteomics, Early secretory pathway, and Protein trafficking from McGill University. Prior to that, they completed their Bachelor of Science degree in Biology at Saint Michael's College.